Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »

View All Information for Patients & Visitors »

View the changes to our visitor policy »

View information for Guest Services »

New to MyHealth?

Manage Your Care From Anywhere.

Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.

CLINICAL TRIALS

About Clinical Trials Find a Clinical Trial

CLINICAL TRIALS

About Clinical Trials Find a Clinical Trial

Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia

Trial ID or NCT#

NCT00504088

Status

NOT RECRUITING

Purpose

To compare the outcome of bypass surgery and plaque excision for treatment of critical limb ischemia in the lower limbs

Official Title

Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years

Sexes Eligible for Study: All

Accepts Healthy Volunteers: No

Inclusion Criteria:

- Ischemic rest pain for more than 2 weeks or ulceration or gangrene of the foot or toes (Rutherford Becker Category 4, 5 or 6) - Willing and able, as evaluated by the PI, to provide Informed Consent - Willing to undergo up to 5 years of clinical follow up visits as scheduled - Angiographic pattern of infrainguinal disease that can be reasonably managed either by surgery or plaque excision in the first instance - Reconstitution of at least one patent target tibial segment below the knee which provides run-off to the foot - The patient must be >18 years of age - Target lesion(s) is located at or below the level of the superficial femoral artery - Target lesion(s) is >50% stenosed by quantitative vascular angiography - Ability to take at least one of the following types of medications: anti- platelet or anti-thrombotic therapy

Exclusion Criteria:

- Patient has cardiac or cardiovascular comorbidities that would make surgery inappropriate - Patient has terminal or Stage 4 cancer - Patient has extensive gangrene that requires both a Below-the-Knee amputation and a revascularization procedure - Previous stent in the target lesion - Active infection at planned incision site - The patient is a pregnant woman - The patient has significant suprainguinal or Common Femoral disease that can not be treated either prior to or during the index procedure - Target Lesion is a Chronic Total Occlusion (CTO) that is greater than 15cm in length and has severe, continuous calcification

View All Criteria

Investigator(s)

Cornelius Olcott

E. John Harris Jr.

Vascular surgeon

Professor of Surgery (Vascular) at the Stanford University Medical Center

Ronald L. Dalman MD

Vascular surgeon

Walter Clifford Chidester and Elsa Rooney Chidester Professor of Surgery

CONTACT

Jason Lee
(650) 725-5227

SEND MESSAGE

View on ClinicalTrials.gov

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia

Trial ID or NCT#

Status

Purpose

Official Title

Eligibility Criteria

Investigator(s)

CONTACT

About this Clinical Trial

Your Message Will Go To

To:

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia

Trial ID or NCT#

Status

Purpose

Official Title

Eligibility Criteria

Investigator(s)

CONTACT

About this Clinical Trial

Your Message Will Go To

To: